Oncology Institute, Inc. — Form 8-K
Filed August 3, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 22/100
What the filing says
Effective August 4, 2026, The Oncology Institute, Inc. completed a corporate rebrand to Starling Oncology, Inc., and its Nasdaq ticker symbol changed from TOI to STLN. The filing contains a certificate of amendment to the company's articles of incorporation reflecting the legal name change. No financial transactions, asset sales, material contracts, financing, or operational changes are disclosed in this 8-K.
Why this rating
Rebrand is administrative and cosmetic—no financial, operational, or strategic substance disclosed. Does not alter business model, financials, or competitive position materially.
See more from August 3, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.